Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MedShapeNet - a large-scale dataset of 3D medical shapes for computer vision.
Li J, Zhou Z, Yang J, Pepe A, Gsaxner C, Luijten G, Qu C, Zhang T, Chen X, Li W, Wodzinski M, Friedrich P, Xie K, Jin Y, Ambigapathy N, Nasca E, Solak N, Melito GM, Vu VD, Memon AR, Schlachta C, De Ribaupierre S, Patel R, Eagleson R, Chen X, Mächler H, Kirschke JS, de la Rosa E, Christ PF, Li HB, Ellis DG, Aizenberg MR, Gatidis S, Küstner T, Shusharina N, Heller N, Andrearczyk V, Depeursinge A, Hatt M, Sekuboyina A, Löffler MT, Liebl H, Dorent R, Vercauteren T, Shapey J, Kujawa A, Cornelissen S, Langenhuizen P, Ben-Hamadou A, Rekik A, Pujades S, Boyer E, Bolelli F, Grana C, Lumetti L, Salehi H, Ma J, Zhang Y, Gharleghi R, Beier S, Sowmya A, Garza-Villarreal EA, Balducci T, Angeles-Valdez D, Souza R, Rittner L, Frayne R, Ji Y, Ferrari V, Chatterjee S, Dubost F, Schreiber S, Mattern H, Speck O, Haehn D, John C, Nürnberger A, Pedrosa J, Ferreira C, Aresta G, Cunha A, Campilho A, Suter Y, Garcia J, Lalande A, Vandenbossche V, Van Oevelen A, Duquesne K, Mekhzoum H, Vandemeulebroucke J, Audenaert E, Krebs C, van Leeuwen T, Vereecke E, Heidemeyer H, Röhrig R, Hölzle F, Badeli V, Krieger K, Gunzer M, Chen J, van Meegdenburg T, Dada A, Balzer M, Fragemann J, Jonske F, Rempe M, Malor… See abstract for full author list ➔ Li J, et al. Among authors: schreiber s. Biomed Tech (Berl). 2024 Dec 30. doi: 10.1515/bmt-2024-0396. Online ahead of print. Biomed Tech (Berl). 2024. PMID: 39733351
A conserved role for ALG10/ALG10B and the N -glycosylation pathway in the sleep-epilepsy axis.
Gill S, Mandigo TR, Elmali AD, Leger BS, Yang B, Tran S, Laosuntisuk K, Lane JM, Bannister D, Aonbangkhen C, Ormerod KG, Mahama B, Schuch KN, Elya C, Akhund-Zade J, Math SR, LoRocco NC, Seo S, Maher M, Kanca O, Bebek N, Karadeniz D, Senel GB, Courage C, Lehesjoki AE, Winkelman JW, Bellen HJ, de Bivort B, Hart AC, Littleton JT, Baykan B, Doherty CJ, Melkani GC, Prober DA, Woo CM, Saxena R, Schreiber SL, Walker JA. Gill S, et al. Among authors: schreiber sl. medRxiv [Preprint]. 2024 Dec 13:2024.12.11.24318624. doi: 10.1101/2024.12.11.24318624. medRxiv. 2024. PMID: 39711723 Free PMC article. Preprint.
Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti-Tumour Necrosis Factor-α in Patients With Crohn's Disease: A Systematic Literature Review and Meta-Analysis.
Armuzzi A, Vermeire S, Chaparro M, Biedermann P, Brown R, McStravick M, Meyer M, Schreiber S. Armuzzi A, et al. Among authors: schreiber s. United European Gastroenterol J. 2024 Dec 21. doi: 10.1002/ueg2.12705. Online ahead of print. United European Gastroenterol J. 2024. PMID: 39707930 Free article.
A randomized phase 2 study of efmarodocokin alfa, an IL-22 agonist, versus vedolizumab in patients with ulcerative colitis.
Danese S, Rothenberg ME, Lim JJ, Ding HT, McBride JM, Chen Y, Dash A, Mar JS, Keir M, Peyrin-Biroulet L, Panes J, Colombel JF, Feagan B, Valentine JF, Schreiber S. Danese S, et al. Among authors: schreiber s. Clin Gastroenterol Hepatol. 2024 Dec 16:S1542-3565(24)01096-6. doi: 10.1016/j.cgh.2024.11.013. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39694207 Free article.
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S. Vermeire S, et al. Among authors: schreiber s. Lancet Gastroenterol Hepatol. 2024 Dec 2:S2468-1253(24)00272-3. doi: 10.1016/S2468-1253(24)00272-3. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 39637881 Free article.
Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance.
Luth MR, Godinez-Macias KP, Chen D, Okombo J, Thathy V, Cheng X, Daggupati S, Davies H, Dhingra SK, Economy JM, Edgar RCS, Gomez-Lorenzo MG, Istvan ES, Jado JC, LaMonte GM, Melillo B, Mok S, Narwal SK, Ndiaye T, Ottilie S, Palomo Diaz S, Park H, Peña S, Rocamora F, Sakata-Kato T, Small-Saunders JL, Summers RL, Tumwebaze PK, Vanaerschot M, Xia G, Yeo T, You A, Gamo FJ, Goldberg DE, Lee MCS, McNamara CW, Ndiaye D, Rosenthal PJ, Schreiber SL, Serra G, De Siqueira-Neto JL, Skinner-Adams TS, Uhlemann AC, Kato N, Lukens AK, Wirth DF, Fidock DA, Winzeler EA. Luth MR, et al. Among authors: schreiber sl. Science. 2024 Nov 29;386(6725):eadk9893. doi: 10.1126/science.adk9893. Epub 2024 Nov 29. Science. 2024. PMID: 39607932
2,827 results